At least 62 people died as a result of dengue fever in the first five weeks of 2024, according to information released this Friday (9) by the Ministry of Health. Another 279 deaths are under investigation.
According to the ministry, the country has 183,186 confirmed cases of the disease and 225,165 are classified as probable. There is a projection of 4.2 million cases of dengue in the country in 2024.
The data was published in the Arbovirus Monitoring Panel, in which the ministry presents the information registered by municipalities in Sinan (Notifiable Diseases Information System).
In addition to dengue, the platform presents updates regarding chikungunya and zika cases. This Friday, the panel indicated 15,017 confirmed cases from that case — with four deaths — and 37 from this one.
The numbers are provisional. Cities can reevaluate cases and modify the information on Sinan, consequently changing the panel.
Another point that affects the outlook is the interval between case confirmation and posting in the national system. The ministry estimates that some cities will take up to a week to fill out Sinan. Thus, records that appear in the fifth week of the year, for example, may be from the fourth.
The same happens with deaths. Records that appear linked to January may be from December, depending on the time elapsed between death, confirmation and notification.
First the children
This Thursday (8), the ministry began distributing dengue vaccines. The states of Goiás, Bahia, Acre, Paraíba, Rio Grande do Norte, Mato Grosso do Sul, Amazonas, São Paulo and Maranhão, as well as the Federal District, will receive the first batch, with 712,184 doses.
In this first delivery, the vaccine will be sent to 315 municipalities, equivalent to 60% of the 521 cities selected to receive the vaccine, and children aged 10 to 11 will be immunized. See here the first places to receive the vaccine and the expected number of doses.
As the pharmaceutical company Takeda delivers new batches of Qdenga, the group will be expanded to include the target audience this year: children and adolescents aged 10 to 14.
The age group was defined among the councils representing the state and municipal health secretaries, following the recommendation of the ministry’s Technical Advisory Chamber on Immunization and the WHO (World Health Organization).